Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,554.00    12.00 (0.47%)
Bid:
2,554.00
Ask:
2,555.00
Spread: 1.00 (0.039%)
Market Cap: £22.76b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Director/PDMR Shareholding

17 Jun 2025 14:00

RNS Number : 2159N
Experian plc
17 June 2025
 

Experian plc

 

 

Director/PDMR Shareholding

 

 

17 June 2025 - Experian plc, the global data and technology company, hereby notifies the market that it has received notification (made under article 19.1 of the UK Market Abuse Regulation ("MAR")) of the following transactions in its ordinary shares of 10 US cents each ("ordinary shares") by directors of the Company.

 

Co-Investment Plan

 

In accordance with the terms of the Experian Co-Investment Plan, the Company made awards over its ordinary shares on 13 June 2025 to certain directors by reference to a price of 3,746.27 pence per share. The awards of deferred matching ordinary shares are subject to performance conditions and the maximum numbers of shares that could vest in the case of each director are set out below.

Name of director/PDMR

Number of deferred

ordinary shares

Maximum number of deferred matching ordinary shares

Brian Cassin

30,157

113,802

Lloyd Pitchford

21,221

80,079

 

Note: The deferred ordinary share awards for Brian Cassin and Lloyd Pitchford were calculated with reference to their bonuses net of tax. All deferred matching ordinary share awards were calculated on a gross basis and will be taxed at the point of vesting.

 

Performance Share Plan

 

In accordance with the terms of the Experian Performance Share Plan, the Company made awards over its ordinary shares on 13 June 2025 to certain directors by reference to a price of 3,775.30 pence per share. The awards are subject to performance conditions and the maximum number of shares that could vest in the case of each director is set out below.

 

Name of director/PDMR

Maximum number

of ordinary shares

Brian Cassin

71,516

Lloyd Pitchford

40,791

 

The following individual notifications are made in accordance with Article 19.3 of MAR.

 

 

1 - Details of the person discharging managerial responsibilities / person closely associated

 

 

 

Natural Person

Brian Cassin

 

 

2 - Reason for the notification

 

 

 

Position/status

Director and Chief Executive Officer

 

 

Initial notification / Amendment

Initial Notification

 

 

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

 

 

Full name of the entity

Experian plc

Legal Entity Identifier code

635400RXXHHYT1JTSZ26

 

 

 

4 - Details of the transaction(s)

 

 

 

 

Description of the financial instrument, type of instrument

 

Ordinary shares of US 10 cents each in Experian plc

 

Identification Code

GB00B19NLV48

 

 

Nature of transaction

(1) Acquisition of shares, being the award of Invested Shares ("deferred ordinary shares") for market value under the Experian Co-Investment Plan.

 

(2) Grant of a conditional right to receive shares for nil consideration, being the grant of a Matching Award ("deferred matching ordinary shares") under the Experian Co-Investment Plan.

 

(3) Grant of a conditional right to receive shares for nil consideration, being the grant of an award under the Experian Performance Share Plan.

 

 

Currency

GBP

 

 

Prices(s) and volumes(s)

Transaction

Price

Volume

No (1)

3,746.27 pence

30,157

No (2)

Nil

113,802

No (3)

Nil

71,516

 

 

Aggregated Information

Transaction

Price

Volume

No (1)

3,746.27 pence

30,157

No (2) and (3)

Nil

185,318

 

 

Date of Transaction

 

2025-06-13

 

 

Place of transaction

Acquisition: XLON

Grant of conditional rights: Outside a trading venue

 

 

 

 

 

 

1 - Details of the person discharging managerial responsibilities / person closely associated

 

 

 

Natural Person

Lloyd Pitchford

 

 

2 - Reason for the notification

 

 

 

Position/status

Director and Chief Financial Officer

 

 

Initial notification / Amendment

Initial Notification

 

 

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

 

Full name of the entity

Experian plc

 

 

Legal Entity Identifier code

635400RXXHHYT1JTSZ26

 

 

 

 

4 - Details of the transaction(s)

 

 

 

 

Description of the financial instrument, type of instrument

 

Ordinary shares of US 10 cents each in Experian plc

 

Identification Code

GB00B19NLV48

 

 

Nature of transaction

(1) Acquisition of shares, being the award of Invested Shares ("deferred ordinary shares") for market value under the Experian Co-Investment Plan.

 

(2) Grant of a conditional right to receive shares for nil consideration, being the grant of a Matching Award ("deferred matching ordinary shares") under the Experian Co-Investment Plan.

 

(3) Grant of a conditional right to receive shares for nil consideration, being the grant of an award under the Experian Performance Share Plan.

 

 

Currency

GBP

 

 

Prices(s) and volumes(s)

Transaction

Price

Volume

No (1)

3,746.27 pence

21,221

No (2)

Nil

80,079

No (3)

Nil

40,791

 

 

Aggregated Information

Transaction

Price

Volume

No (1)

3,746.27 pence

21,221

No (2) and (3)

Nil

120,870

 

 

Date of Transaction

 

2025-06-13

 

 

Place of transaction

Acquisition: XLON

Grant of conditional rights: Outside a trading venue

 

 

 

 

Experian

Claire Murphy Deputy Company Secretary +353 (0) 87 421 3311

 

 

About Experian

 

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

 

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

 

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 23,300 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGPUBGQUPAGGM
Date   Source Headline
16th Aug 20239:16 amRNSAdditional Listing
9th Aug 20239:30 amRNSAdditional Listing
2nd Aug 20239:16 amRNSAdditional Listing
31st Jul 202312:05 pmRNSTotal Voting Rights
26th Jul 202310:00 amRNSAdditional Listing
25th Jul 20232:30 pmRNSDirector/PDMR Shareholding
25th Jul 202310:30 amRNSDirector/PDMR Shareholding
19th Jul 20232:32 pmRNSAdditional Listing
19th Jul 202312:22 pmRNSResult of AGM
13th Jul 20237:00 amRNSTrading update, first quarter
12th Jul 20239:30 amRNSHolding(s) in Company
11th Jul 20234:00 pmRNSHolding(s) in Company
6th Jul 20233:00 pmRNSHolding(s) in Company
30th Jun 20235:32 pmRNSSecond Interim Dividend
30th Jun 202310:30 amRNSTotal Voting Rights
28th Jun 202310:00 amRNSAdditional Listing
23rd Jun 202310:00 amRNSDirector/PDMR Shareholding
22nd Jun 202310:55 amRNSDirector/PDMR Shareholding
21st Jun 202311:00 amRNSAdditional Listing
14th Jun 202312:00 pmRNSAdditional Listing
14th Jun 202310:00 amRNSDirector/PDMR Shareholding
9th Jun 20234:00 pmRNSAnnual Financial Report
7th Jun 20233:49 pmRNSDirector/PDMR Shareholding
2nd Jun 20239:00 amRNSElections for second interim dividend
31st May 20231:12 pmRNSTotal Voting Rights
31st May 20239:32 amRNSAdditional Listing
22nd May 202312:46 pmRNSDirector/PDMR Shareholding
18th May 20232:29 pmRNSDirector/PDMR Shareholding
18th May 202310:20 amRNSDirector/PDMR Shareholding
17th May 20234:00 pmRNSDirector/PDMR Shareholding
17th May 202311:00 amRNSShare repurchases
17th May 20237:00 amRNSFull-year financial report
28th Apr 202310:15 amRNSTotal Voting Rights
12th Apr 20239:30 amRNSAdditional Listing
4th Apr 20239:45 amRNSAdditional Listing
31st Mar 202311:35 amRNSTotal Voting Rights
29th Mar 20239:20 amRNSAdditional Listing
28th Mar 20237:00 amRNSDirectorate Change
22nd Mar 20235:19 pmRNSTransaction in Own Shares
22nd Mar 20239:15 amRNSAdditional Listing
20th Mar 20235:18 pmRNSTransaction in Own Shares
17th Mar 20235:31 pmRNSTransaction in Own Shares
16th Mar 20235:09 pmRNSTransaction in Own Shares
16th Mar 20239:15 amRNSBlock listing Interim Review
15th Mar 20235:14 pmRNSTransaction in Own Shares
15th Mar 20239:15 amRNSAdditional Listing
14th Mar 20235:21 pmRNSTransaction in Own Shares
13th Mar 20235:31 pmRNSTransaction in Own Shares
10th Mar 20236:10 pmRNSTransaction in Own Shares
9th Mar 20235:22 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.